Published in J Am Coll Cardiol on March 12, 2013
Relationship Between OCT Coronary Plaque Morphology and Clinical Outcome (CLIMA) | NCT02883088
Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions. Eur Heart J (2016) 1.58
Diagnosis of Thin-Capped Fibroatheromas in Intravascular Optical Coherence Tomography Images: Effects of Light Scattering. Circ Cardiovasc Interv (2016) 1.41
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol (2015) 1.01
Imaging Atherosclerosis. Circ Res (2016) 0.95
Automated Quantitative Plaque Burden from Coronary CT Angiography Noninvasively Predicts Hemodynamic Significance by using Fractional Flow Reserve in Intermediate Coronary Lesions. Radiology (2015) 0.88
Cardiac CT: atherosclerosis to acute coronary syndrome. Cardiovasc Diagn Ther (2014) 0.88
Plaque assessment by coronary CT. Int J Cardiovasc Imaging (2015) 0.87
Extracellular vesicles in coronary artery disease. Nat Rev Cardiol (2017) 0.84
Assessment of coronary artery disease using coronary computed tomography angiography and biochemical markers. World J Cardiol (2014) 0.83
Quantification of fibrous cap thickness in intracoronary optical coherence tomography with a contour segmentation method based on dynamic programming. Int J Comput Assist Radiol Surg (2015) 0.83
Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors. Sci Rep (2016) 0.83
In vivo semi-automatic segmentation of multicontrast cardiovascular magnetic resonance for prospective cohort studies on plaque tissue composition: initial experience. Int J Cardiovasc Imaging (2015) 0.83
Imaging plaques to predict and better manage patients with acute coronary events. Circ Res (2014) 0.82
Differences determined by optical coherence tomography volumetric analysis in non-culprit lesion morphology and inflammation in ST-segment elevation myocardial infarction and stable angina pectoris patients. Catheter Cardiovasc Interv (2014) 0.81
Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification. Virchows Arch (2014) 0.81
Salt in the wound: (18)F-fluoride positron emission tomography for identification of vulnerable coronary plaques. Cardiovasc Diagn Ther (2015) 0.80
High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics. Atherosclerosis (2014) 0.79
Scintillating balloon-enabled fiber-optic system for radionuclide imaging of atherosclerotic plaques. J Nucl Med (2015) 0.79
Imaging atherosclerosis and risk of plaque rupture. Curr Atheroscler Rep (2013) 0.79
Pathomorphological and CT-angiographical characteristics of coronary atherosclerotic plaques in cases of sudden cardiac death. Int J Legal Med (2015) 0.79
CD40 in coronary artery disease: a matter of macrophages? Basic Res Cardiol (2016) 0.78
A novel method for non-invasive plaque morphology analysis by coronary computed tomography angiography. Int J Cardiovasc Imaging (2014) 0.77
Synergistic effect of local endothelial shear stress and systemic hypercholesterolemia on coronary atherosclerotic plaque progression and composition in pigs. Int J Cardiol (2013) 0.76
Role of computed tomography for diagnosis and risk stratification of patients with suspected or known coronary artery disease. Arterioscler Thromb Vasc Biol (2014) 0.76
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach. Nucl Med Biol (2015) 0.76
Automatic Lumen Segmentation in Intravascular Optical Coherence Tomography Images Using Level Set. Comput Math Methods Med (2017) 0.75
Positron emission tomography imaging of coronary atherosclerosis. Future Cardiol (2016) 0.75
Noninvasive diagnosis of vulnerable coronary plaque. World J Cardiol (2016) 0.75
Aortic Wall Extracellular Matrix Proteins Correlate with Syntax Score in Patients Undergoing Coronary Artery Bypass Surgery. Open Cardiovasc Med J (2016) 0.75
In search of the elusive vulnerable plaque: reducing the gap between coronary imaging and necropsy findings. J Am Coll Cardiol (2013) 0.75
Real-time intravascular photoacoustic-ultrasound imaging of lipid-laden plaque in human coronary artery at 16 frames per second. Sci Rep (2017) 0.75
Non-invasive assessment of low- and intermediate-risk patients with chest pain. Trends Cardiovasc Med (2016) 0.75
Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA2 in Macrophages. Front Physiol (2017) 0.75
Decreased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability. Exp Ther Med (2017) 0.75
Sex-related differences in serum matrix metalloproteinase-9 screening non-calcified and mixed coronary atherosclerotic plaques in outpatients with chest pain. Heart Vessels (2017) 0.75
Pericoronary adipose tissue ratio is a stronger associated factor of plaque vulnerability than epicardial adipose tissue on coronary computed tomography angiography. Heart Vessels (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2000) 14.59
A Wilcoxon-type test for trend. Stat Med (1985) 13.22
A prospective natural-history study of coronary atherosclerosis. N Engl J Med (2011) 10.66
Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med (1987) 9.79
Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation (2003) 8.29
Coronary plaque disruption. Circulation (1995) 8.04
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol (2009) 5.70
Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med (2003) 5.43
Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J (1998) 5.09
Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med (1997) 5.09
Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke (2006) 4.85
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol (2005) 4.29
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol (2006) 3.91
In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation (2005) 3.23
Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol (2006) 3.16
The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med (1992) 3.16
Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation (2001) 3.13
Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol (2007) 2.97
Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study. Circulation (2000) 2.76
Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation (2002) 2.39
Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging (2010) 2.38
Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation (2005) 2.36
Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation (2004) 2.00
Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation (2002) 1.85
Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. JACC Cardiovasc Imaging (2011) 1.83
Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging (2012) 1.77
Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol (1985) 1.68
Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol (2000) 1.64
Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart (1999) 1.59
Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. Eur Heart J (2011) 1.53
Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med (2005) 1.26
Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol (1986) 1.24
Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging. Circ J (2007) 1.15
The composition of coronary-artery plaques. N Engl J Med (1997) 1.15
In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. Eur Heart J (2011) 1.09
Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med (2008) 1.05
Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol (2006) 1.02
The popcorn plaques. Nat Med (2007) 0.99
Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography. Circulation (2007) 0.95
Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med (2009) 0.94
Fusion of positron emission tomography and coronary computed tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake in the left main coronary artery soft plaque. J Nucl Cardiol (2008) 0.90
Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging (2008) 0.88
Noninvasive detection of vulnerable coronary plaques: Locking the barn door before the horse is stolen. J Am Coll Cardiol (2009) 0.83
Coronary CT angiography: an established, not emerging, basis of diagnosis and risk stratification. JACC Cardiovasc Imaging (2011) 0.80
Cardiovascular imaging quality-more than a pretty picture! JACC Cardiovasc Imaging (2008) 0.79
Coronary CT angiography and comparative effectiveness research prognostic value of atherosclerotic disease burden in appropriately indicated clinical examinations. JACC Cardiovasc Imaging (2011) 0.78
Beyond the glass ceiling--achieving gender equity in risk stratification for cardiovascular imaging. JACC Cardiovasc Imaging (2011) 0.78
The role of radionuclide cardiac imaging in coronary artery bypass surgery. Am Heart J (1987) 0.78
Molecular imaging of coronary inflammation: overcoming hurdles one at a time... JACC Cardiovasc Imaging (2010) 0.78
Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride. JACC Cardiovasc Imaging (2011) 0.77
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol (2006) 8.27
Pathology of the vulnerable plaque. J Am Coll Cardiol (2006) 7.79
Who is at greatest risk for receiving poor-quality health care? N Engl J Med (2006) 6.69
Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA (2005) 5.83
Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol (2009) 5.70
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation (2004) 5.44
Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med (2003) 5.43
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation (2007) 5.05
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet (2011) 4.67
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol (2002) 4.48
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol (2012) 4.29
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol (2005) 4.29
Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med (2004) 4.18
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg (2006) 3.77
The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol (2011) 3.71
Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol (2010) 3.45
In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol (2013) 3.43
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med (2007) 3.40
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol (2005) 3.38
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation (2012) 3.38
Low-grade carotid stenosis: looking beyond the lumen with MRI. Stroke (2005) 3.28
Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol (2007) 2.97
Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol (2007) 2.95
Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation (2007) 2.93
Cardiac tumours: an update: Cardiac tumours. Heart (2008) 2.81
Looking forward, looking back: assessing variations in hospital resource use and outcomes for elderly patients with heart failure. Circ Cardiovasc Qual Outcomes (2009) 2.80
Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation (2009) 2.67
Training cardiovascular fellows in cardiovascular magnetic resonance and vascular imaging; Current status following the core cardiovascular training symposium (COCATS-2) guidelines. J Am Coll Cardiol (2004) 2.67
Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation (2008) 2.64
A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci U S A (2006) 2.61
Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol (2009) 2.59
Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect (2005) 2.57
Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging (2010) 2.56
Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging (2009) 2.56
Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol (2004) 2.54
Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol (2002) 2.53
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med (2008) 2.52
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation (2003) 2.52
Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation (2008) 2.52
Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol (2006) 2.51
Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging (2012) 2.50
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation (2007) 2.50
Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol (2006) 2.50
Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol (2009) 2.49
Left ventricular noncompaction: a pathological study of 14 cases. Hum Pathol (2005) 2.48
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation (2009) 2.47
Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol (2008) 2.45